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The book divides into five main sections. The first sec-
tion is very general and deals with statistical concepts and
thinking and a chapter that summarizes how often various
statistical procedures are used in the New England Journal
of Medicine. Section 2 discusses probably the most important
aspect of any person’s research, namely, the actual design of
the study. The concepts are presented in a very simplified
way, and different designs are well illustrated with relevant
examples. My one minor criticism is that the two chapters on
study power (chapter 19) and statistical consultancy (chapter
18) would have been better placed in this section, empha-
sizing the importance of both at the early design stage of a
study. Although the actual size of the study is often limited
by various constraints (financial, time, and subjects available
for study), the final sample size has ramifications for the
methods of analysis and any faith placed in the results. In
addition, my personal view is that (where necessary), the
sooner a study involves the expertise of a qualified statisti-
cian, the better that study will be designed and ultimately
analyzed appropriately. Section 3 describes various methods
of analysis and common problems incurred with their use.
This section includes an excellent chapter about the overem-
phasis (often placed by nonstatisticians) on P values and their
common misuse (chapter 10). Section 4 is mainly concerned
with the reporting of results and gives direct, practical advice
regarding the writing up of research and maximizing one’s
chances of publication. The final section includes two new
chapters on meta-analysis, an increasingly popular method of
summarizing research in a common area. There is direct,
practical advice on how to appraise a completed meta-analysis
that the reader may find particularly helpful.
This second edition is not merely a rehash and update of
the first edition, since seven new chapters have been includ-
ed and others have been updated or rewritten. Detailed dis-
cussion and illustrations of both good and poor use of the
various concepts are provided in each chapter. This gives any
reader who may be unfamiliar with a particular technique a
firm grounding as to the best way to proceed and some com-
mon pitfalls to avoid. Being very practically oriented, the
book would be especially useful to those readers with limit-
ed or no prior knowledge of statistics, whether physicians,
surgeons, or medical students. In conclusion, I found the
book to be well written, easy to read, and a useful addition
to any biomedical researcher’s bookshelf.
Amanda Lee, PhD
Wolfson Unit for Prevention of Peripheral Vascular Diseases
Department of Public Health
The University of Edinburgh
Edinburgh, Scotland
doi:10.1067/mva.2001.111786
Cardiac drug therapy, 5th ed
M. Gabriel Khan; London; 1999; WB Saunders; 446 pages.
The fifth edition of Cardiac Drug Therapy represents a
concise handbook from which cardiac medications can be
quickly referenced. Practical, scientifically based information
concerning the wide variety of currently available cardiac
drugs is provided in an easily accessible format. Basic phar-
macology, management strategies, treatment algorithms,
and important information pertinent to each drug blend
together well in a complementary fashion.
The first four chapters give a succinct review of beta-
blockers, angiotensin-converting enzyme inhibitors, calcium
channel blockers, and diuretics. A major strength of this sec-
tion is the author’s attempt to help the reader decide,
depending on the clinical scenario, which drugs to use and
which to avoid. The chapter that focuses on beta-blockers is
especially well written. Beta-blockers have been shown to
decrease cardiac morbidity and mortality, and their use has
been shown to be of particular benefit in the perioperative
care of patients with cardiovascular disease. The author stress-
es the important benefits of beta-blockers and the numerous
indications for this therapy. The chapter appropriately empha-
sizes the relative underutilization of beta-blockers and pro-
vides a convincing argument for an increase in the use of these
drugs by primary care physicians. Given the underutilization,
more emphasis could have been placed on instructing the sur-
geon as to which beta-blocker to use preoperatively when
faced with performing surgery on a patient with cardiovascu-
lar disease and time/dose details of administration.
Much of the rest of the book addresses specific clinical
scenarios such as hypertension, angina, acute myocardial
infarction, heart failure, and cardiac arrhythmias. With a
wide variety of medications available for treatment, con-
cise, effective algorithms with minimal complexity are
needed. Dr Khan accomplishes this formidable task. The
handbook is made more complete, while remaining com-
pact in size, with the addition of information on hyper-
lipidemia treatment, antiplatelet agents, endocarditis ther-
apy, and cardiac drug interactions with pregnancy.
Dr M. Gabriel Khan represents the sole author of this
fifth edition. However, even with the inherent limitations
of a handbook, each chapter is extremely well referenced
to provide “evidence based medicine.” Dr Khan, who
practices cardiology at the University of Ottowa, brings
the book to an international audience with its additional
publication in Spanish and French.
The handbook should be a useful reference to a broad
range of clinicians. For surgeons who commonly operate on
patients with associated cardiac disease, the book provides
helpful information to assist in wading through the plethora
of new medications that their patients may be taking. While
variability may exist as to which drug may be the best for a
particular cardiac problem, the handbook provides reliable
information that is easy to understand and well referenced.
Therefore, when one is faced with the question of which drug
to use, Cardiac Drug Therapy will provide the reader with
ready access to practical information to assist in selecting the
optimal medication that will be both safe and effective.
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